Omeros Corporation

Receive alerts:
by e-mail
E-mail Your information will be added to a database with the sole purpose of serving your subscription. This database is the exclusive property of vLex Networks S.L. and will never be shared with any other company. By sending your request you accept the Data Protection Policy of vLex Networks S.L. I have read and accept the Terms of Use
via RSS

29 documents for Omeros Corporation

- The Law Firm of Davis Wright Tremaine Announces That Richard Klein, Former CFO of Seattle Biopharmaceutical Company Omeros Corp., Receives $3.9 Million to Settle Whistleblower Suit.
... biopharmaceutical company Omeros Corporation, has received a $3.94 million payment to settle hi...
- Business Wire
- November 08, 2012
- OMEROS REPORTS 3RD QTR 2010 NET LOSS OF $7.6 MILLION.
Omeros Corporation (Nasdaq: OMER), Seattle, a biopharmaceutical compa...
- Biotech Financial Reports
- Vol. 17 Nbr. 12, December 2010
- Piper Jaffray Hosts 23rd Annual Healthcare Conference.
....; Array BioPharma Inc.; ArthroCare Corporation; Astex Pharmaceuticals, Inc.; Athersys, Inc.; Atri..., Inc.; Obagi Medical Products, Inc.; Omeros Corporation; Omnicell, Inc.; OMNIlife science, Inc...
- Business Wire
- November 21, 2011

- Ernst & Young Entrepreneur Of The Year[R] Award Semi-Finalists in the Pacific Northwest Announced.
...* Gregory Demopulos, M.D., Omeros Corporation, Seattle, WA. * Bohn Crain, Radiant Lo...
- Business Wire
- April 06, 2011
- Accelerator Corporation Names David McElligott, Ph.D. as Chief Scientific Officer.
...who recently joined Omeros Corporation (NASDAQ:OMER) as Scientific Fellow. Dr...
- Business Wire
- March 28, 2012
- Research and Markets: Metastatic Melanoma - Pipeline Review, H1 2012
Research and Markets Laura Wood, Senior Manager.

...-- Celgene Corporation. -- 3SBio Inc. -- EpiCept Corporation. -- Celldex ...-- Myriad Pharmaceuticals, Inc. -- Omeros Corporation. -- Immunocore Limited. -- CureTech Lt...
- Business Wire
- March 28, 2012
- Research and Markets: Nicotine Addiction - Pipeline Review, H2 2012
Research and Markets Laura Wood, Senior Manager.

...- EnVivo Pharmaceuticals. - Omeros Corporation. - Selecta Biosciences, Inc. - Heptare...
- Business Wire
- January 17, 2013
- Accelerator Corporation Names David Mcelligott, Ph.D. As Chief Scientific Officer
Accelerator Corporation Jessica Burback, 206-957-7300

...who recently joined Omeros Corporation (NASDAQ:OMER) as Scientific Fellow. Dr...
- Business Wire
- March 28, 2012
- Research and Markets: Drug Abuse - Pipeline Review, Q1 2011 Reviews Key Players Involved In the Therapeutic Development for Drug Abuse.
...* Baylor College of Medicine. * Omeros Corporation. * AIKO Biotechnology, Inc. * Embera N...
- Business Wire
- February 24, 2011
- Research and Markets: Addiction - Pipeline Review: Latest Updates and Review of Key Players
Research and Markets Laura Wood, Senior Manager.

...- Abbott Laboratories. - Aradigm Corporation. - Tekmira Pharmaceuticals Corp. - Alkermes, Inc. ...- Global Health Ventures Inc. - Omeros Corporation. - ImmunoVaccine Technologies Inc. - T...
- Business Wire
- January 09, 2013